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Abstract
BACKGROUND: Vitamin D and VDRs FokI has been reported to be strongly associated with type 2 diabetes mellitus 
(T2DM) through controlling inflammation of endothelial cells in diabetic foot cases.
AIM: This study aimed to detect Vitamin D receptor FokI polymorphisms and to determine the Vitamin D levels 
among diabetic foot patients in sunlight-rich areas.
MATERIALS AND METHODS: A cross sectional study was conducted among diabetic foot patients who were 
treated as T2DM, from November 2016 to June 2018 in Padang city, Indonesia. There are an inclusion and exclusion 
criteria listed below. A questionnaire for symptoms-based screening, ankle brachial index (ABI) examination, fasting 
glucose, and HbA1c were measured. Electroimmunoassay (ECLIA) was used to determine Vitamin D levels as 
sufficiency, insufficiency, and deficiency. Polymerase chain reaction assay was addressed for VDR FokI genetic 
polymorphisms. Data were analyzed to evaluate the differences of explanatory variables (age, gender, duration 
of T2DM, fasting blood sugar, body mass index [BMI], HbA1c, and Vitamin D levels) across different genotypes of 
VDR FokI for three groups based on the absent T allele (ff: wild type homozygous, Ff: mutant heterozygous, and FF: 
mutant homozygous).
RESULTS: Among 36 eligible subjects, 52.8% were females, 61.1% were <50 years old, 63.9% had normal BMI, and 
86.1% had normal ABI. Vitamin D deficiency, insufficiency, and sufficiency were shown in 19.4%, 33.3%, and 47.2% 
of the subjects, respectively. The majority of VDR FokI gene polymorphisms were mutant heterozygous Ff (44.4%), 
wild type homozygous ff (13.9%), and mutant homozygous FF (41.7%). Results of one-way ANOVA showed that 
there were no differences of BMI, ABI, fasting blood glucose, Vitamin D levels, and Hb1AC status with the VDR FokI 
gene polymorphisms. Based on Vitamin D levels, most of the Vitamin D deficiency subjects had 31.2% VDR FokI Ff 
allele, 13.3% had FF allele, and none of them had ff allele.
CONCLUSION: This study concluded that most of the individuals with diabetic foot in a sunlight-rich area tended to 
have mutant VDR FokI polymorphisms and Vitamin D insufficiency.
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Introduction
The most common microvascular complication 
of type 2 diabetes mellitus (T2DM) is diabetic foot 
with the prevalence around 25% [1], [2]. The process 
is initiated by chronic hyperglycemia, endothelial 
dysfunction, and cytokines secretion which result in 
chronic inflammation, decreasing nitric oxide (NO) 
production, and triggering atherosclerosis [2], [3], [4]. 
Clinically, skin lesions found in diabetic foot patients 
can develop into gangrene and chronic inflammation, 
with an increased risk of secondary infections, and a 
2% chance of amputation [5]. Therefore, disruption of 
patient movement and reduction of individual activity 
lead to a disabling condition.
Vitamin D, known as the sunshine vitamin, 
has been understood as an important key for 
controlling inflammation of endothelial cells, through 
Vitamin D receptors (VDRs). Hypo vitamin D and VDR 
polymorphisms are strongly associated with diabetes 
and cardiovascular diseases [6], [7], [8], [9]. The genetic 
role of Vitamin D in T2DM has been well-demonstrated, 
and different variants of VDR gene FokI are associated 
with T2DM [10], [11], [12], [13]. The human VDR genes 
are located in chromosome 12q12-q14, and the FokI 
polymorphism (ATG-ACG) are in the exon 2 of the 
gene, with a unique function to change the structure of 
the VDR protein and then produce two different protein 
variants. FokI gene with f allele (T amino acid) encodes 
427 amino acid proteins while the F allele (C amino 
acid) encodes 424 amino acid proteins [11], [14]. It 
makes the shorter variant increases its binding capacity 
to 1, 25-dihydroxyvitamin D [15].
The higher level of Vitamin D might enhance 
pancreatic β-cell secretion function and improve insulin 
resistance [12]. However, the biological association 
between the absent of allele in FokI polymorphisms and 
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the susceptibility to T2DM cannot be clearly determined 
due the wide variety of study methods [16], [17]. This 
study aimed to determine the status of Vitamin D and 
to detect the FokI VDR polymorphisms among diabetic 
foot patients in sunlight-rich areas.
Materials and Methods
Research ethics
Ethics clearance was approved by the Ethics 
Committee of Medical Faculty of Andalas University 
(No: 297/KEP/FK/ 2016). Written informed consent was 
obtained from all subjects before the start of the study, 
after they got information about the procedures.
Patients
This is part of the study on the effect of Vitamin 
D supplementation in diabetic foot patients. Diabetic 
foot outpatients treated at Ibnu Sina and Dr. Rasyidin 
General Hospital, aged 40–65 years, had HbA1c level 
>6.5% (normal <6.5), and ankle-brachial index (ABI) 
between 0.4 and 1.2 (normal 0.9–1.3) were included 
in this study. Diagnosis and clinical treatment of T2DM 
were performed by internists or endocrinologists. T2DM 
patients with arterial complications: Occlusion, bleeding, 
and with organ diseases that affected Vitamin D 
metabolism such as osteoporosis, hypoparathyroidism, 
the complication of diabetic or hypertension, ankle 
lesions or ulcers, infection, and sepsis were excluded 
from the study.
Samples
Sample collections began with initial selection 
through patients medical records. Subjects fulfilled 
the inclusion and exclusion criteria were selected 
consecutively. A questionnaire for symptom-based 
screening and ABI examination was performed by vascular 
surgeons. Demographic data on age, gender, body weight, 
and height were recorded. Fasting blood glucose, HbA1c, 
Vitamin D levels, and VDR FokI genetic polymorphisms 
were examined. Vitamin D serum levels were measured 
by electroimmunoassay (ECLIA) using a COBAS analyzer 
at Biomedical Laboratory of Medical Faculty of Andalas 
University and were classified as sufficiency >30 ng/mL 
(75–80 nM), insufficiency 20–30 ng/mL (75–80 nM), and 
deficiency <20 ng/mL (50 nM) [18].
Polymerase chain reaction (PCR)
DNA isolation, amplification, and restrictions 
were done to get the PCR results. The isolation 
process was carried out using the PureLink™ Genomic 
DNA Mini Kit Invitrogen, through DNA incubation and 
homogenization at 55°C, followed by centrifuge 1000 g 
for 10 min to binding, washing with 500 μl wash buffer 1 
twice and then DNA eluting.
Furthermore, FokI VDR gene amplification 
was carried out by PCR process using PCR solutions 
that consist of 12.5μl Go Tag Green Master Mix 
(Promega), 1 μl Primer Forward VDR FokI (10 μM), 
1 μl Primer Reverse VDR FokI (10 μM), 3 μl DNA, and 
7.5 μl Nuclease Free Water, for total volume 25 μl. 
The PCR cycle conditions were denaturation at 95°C 
for 3 min, followed by 35 cycles initial denaturation at 
95°C for 30 s, annealing at 59°C for 30 s, elongation at 
72°C for 55 s and the last elongation at 72°C for 5 min. 
Electrophoresis process was been done for 60 min on 
1.5% agarose gel resulting PCR product with length 
250 base pair (bp).
Restrictions process was done using 
Restriction Fragment Length Polymorphism-PCR 
methods with FokI restriction enzyme, forward primer 
(5’-CACTGACTCTGGCTCTGACCGT-3’), and reverse 
primer (5’-AACACCTTGCTTCTTCTCCCTCC-3’) [14]. 
The 3 μl PCR amplicon with 1 μl FokI restriction enzyme, 
2 μl Buffer Green, and 24 μl Nuclease Free Water for 
total restriction reaction volume of 30 μl were digested 
overnight at 37°C. All digest products were analyzed 
by electrophoresis on a 1.5% agarose gel for 60 min 
at 120 V, resulting PCR products with length 192 and 
58 bp for homozygous (TT) and 250, 192, and 58 bp 
for heterozygous samples (TC) and homozygous CC 
remained uncut. Some of the amplification results were 
sent for sequencing at Macrogen Laboratory, South 
Korea.
Data analysis
We analyzed data using SPSS Statistics 
version 22.0 (IBM, NY, USA). Descriptive statistics 
was used to describe the characteristics of the study 
population, including age, sex, disease duration, 
blood sugar levels, HbA1c, and Vitamin D levels. 
One-way ANOVA (for normally distributed variables) 
or Kruskal–Wallis (for non-parametric variables) 
tests were used to evaluate the difference between 
explanatory variables across different genotypes of 
VDR FokI.
Results
Characteristic of study subjects
Characteristics of diabetic foot subjects are 
shown in Table 1. Of 36 subjects, 52.8% were female, 
61.1% <50 years, 63.9% had normal body mass index 
(BMI), and most of them with normal ABI (86.1%). 
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Vitamin D deficiency, insufficiency, and sufficiency were 
observed in 19.4%, 33.3%, and 47.2% of the study 
subjects, respectively. The majority of the subjects 
had FokI VDR gene polymorphisms, that is, mutant 
heterozygous Ff (44.4%) and mutant homozygous FF 
(41.7%).
Results from one-way ANOVA and Kruskal–
Wallis tests showed that there were no differences 
(p > 0.05) of BMI, ABI, fasting blood glucose, Hb1AC 
level, and Vitamin D levels across VDR FokI genotypes 
(Table 2).
Table 2: Mean of variables based on VDR FokI genotypes
Variable (mean) VDR FokI genotypes p-value
ff (mean ± SD) Ff (mean ± SD) FF (mean ± SD)
BMI 20.6 ± 4.1 23.9 ± 4.4 23.3 ± 3.9 0.335*
ABI 1.04 ± 0.09 1.06 ± 0.17 0.99 ± 0.15 0.604**
Fasting blood glucose 
(mg/dL)
202.8 ± 65.7 174.6 ± 74.7 154.3 ± 75.2 0.345**
Vitamin D (ng/mL) 35.8 ± 13.5 28.9 ± 9.4 29.0 ± 10.2 0.399*
HbA1c (%) 11.2 ± 2.4 10.3 ± 2.6 9.9 ± 2.0 0.537*
*One-way ANOVA test, **Kruskal–Wallis test. ABI: Ankle brachial index, BMI: Body mass index.
After stratifying subjects based on VDR FokI 
genotypes and Vitamin D levels, we found that most 
of the Vitamin D deficiency subjects had VDR FokI 
heterozygous mutant Ff (31.2%) and none of them had 
homozygous wild type ff (0%) (Figure 1), no statistical 
significant differences were observed (p > 0.05). When 
we classified as allele subgroups, all VDR FokI gene 
with F allele mutant had more frequent Vitamin D 
deficiency status than f allele (54.8% vs. 40%), on the 
other hand in sub group VDR FokI with f allele wild type, 
Vitamin D deficiency status is not frequent as compare 
to F allele ( 45.2% vs. 60%).
Discussion
Diabetic foot is the most common micro 
vascular complications in T2DM. Factors associated 
with its development have not been fully understood, 
but many studies assume that it occurs secondary to 
micro angiopathy due to late diabetic complications. 
The involvement of Vitamin D and VDR FokI gene 
polymorphisms has been suggested in the development 
of worsening inflammation in T2DM [12], [13].
In the present study, 61.1% of the diabetic foot 
patients were <50 years old. This is relatively different with 
results from other studies. Two studies of the Indonesian 
population in other regions such as Manado and Denpasar 
reported that the majority of diabetic patients were ≥50 years 
(76.3%) and 50–59 years (46.9%), respectively [19], [20]. 
Other reports from India and a meta-analysis also provide 
data that diabetic foot was predominantly shown in older 
patients (aged >50 years) [21], [22], [23], [24]. This difference 
might due to the high proportion of patients (33.3%) in our 
study being diagnosed with T2DM when they were <40 
years old. This condition might have resulted in an earlier 
worsening of vascular endothelium due to the long-term 
chronic hyperglycemia. Consistent with the other studies, 
a positive association was shown between foot ulcer and 
age [25], [26].
In our study, the proportion of females with 
diabetic foot was higher than males and females were 
more likely to develop T2DM at an earlier age than 
males. This is supported by another study in Lampung, 
Indonesia, showing that the prevalence of diabetic foot 
females was higher than males (65% vs. 34.7%) [27]. 
This is possibly due to cultural reasons, given that 
most of the Indonesian women are housewife, getting 
married at an early age, and not frequently doing 
outdoor activities. In addition, most of the Indonesian 
women are Moslems wearing full-body garments. 
This lack of exposure to sunlight might prevent the 
synthesis of Vitamin D, causing Vitamin D deficiency 
and diabetes. This finding is similar to another study 
by Malik et al. in the Kashmir valley [28]. In contrast, 
a meta-analysis showed that males were relatively 
more frequent to develop T2DM than females (11.2 vs. 
9.91%) [29]. Another study also reported that males had 
2.2 times higher incidence and prevalence of diabetic 
foot compared to females, caused by higher physical 
activity that contributes to diabetic ulcers [30].
In general, diabetic foot patients in our study had 
normal BMI. Among individuals who had VDR FokI with 
F allele, BMI values were higher than those with f allele, 
but no statistical difference was observed. Some studies 
provide evidence that body size (reflected by BMI) has 
Table 1: Demographic characteristic in diabetic foot subjects
Variable n (%)
Age
≥50 years old 14 (38.9)
<50 years old 22 (61.1)
Gender
Female 19 (52.8)
BMI
Underweight 2 (5.6)
Normal 23 (63.9)
Overweight 9 (25.0)
Obese 2 (5.6)
ABI
0.4–0.9 4 (11.1)
0.9–1.3 31 (86.1)
>1.3 1 (2.8)
Vitamin D status
Deficiency 7 (19.4)
Insufficiency 12 (33.3)
Sufficiency 17 (47.3)
VDR genotype
Wild type (ff) 5 (13.9)
Heterozygote mutant (Ff) 16 (44.4)
Homozygote mutant (FF) 15 (41.7)
ABI: Ankle brachial index, BMI: Body mass index.
Figure 1: Diagram of Vitamin D status based on VDR FokI genotype 
subgroups (p > 0.05)
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relationships with either Vitamin D levels or VDR [31], [32]. 
VDR is present in adipocytes and plays a role in modulating 
this active metabolic tissue in obese individuals [33]. Caron 
et al. reported that Vitamin D was negatively associated 
with adipocyte size, but this association was only shown in 
women [34]. This might explain our insignificant difference 
of BMI between these two VDR FokI alleles, as our study 
population was dominated by females. However, the 
relationship between VDR FokI polymorphisms and BMI 
is not consistent; some studies reported no significant 
association [31], [32], whereas other studies found an 
association between both of them [35].
Low Vitamin D levels have been associated 
with an increase in cytokine concentrations in diabetic 
foot subjects causing delayed wound healing [36]. In 
this study, 52.7% of diabetic foot subjects had Vitamin D 
levels <20 ng/mL (33.3% insufficiency and 19.4% 
deficiency). A study in multi-ethnic subjects at risk for 
T2DM also reported similar conditions where Vitamin D 
levels were significantly associated to insulin resistance 
and beta-cell dysfunction [37]. These findings highlight 
the importance of Vitamin D to the development of 
inflammation in T2DM patients [36], [38].
Our results revealed that the frequencies of 
both mutant VDR FokI Ff (44.4%) and FF (13.9%) 
genotypes were higher and tended to have lower Vitamin 
D levels compared to wild type alleles (ff) among diabetic 
foot subjects. Several reports on the effect of VDR 
polymorphisms to basal serum Vitamin D levels due 
to insulin secretion and necessary to maintain glucose 
tolerance [39], [40]. There has been known that the FokI 
single-nucleotide polymorphism is capable of changing the 
protein structure and produces two different protein variants 
with different activities [10], [11]. The T allele changing into 
the C allele is suspected to affect insulin sensitivity [11], [14]. 
It is possible that genetic variants of the VDR gene may 
contribute to the development of diabetes [40]. However, 
it remains inconsistent, since a meta-analysis showed no 
significant relationship between VDR polymorphisms and 
risk of T2DM among Asian population [13].
Our study has some limitation that should be 
acknowledged. As this study only aimed to evaluate 
the association of Vitamin D levels with VDR FokI 
polymorphisms, the cause of Vitamin D deficiency cannot 
be presented. The small number of subjects might have 
reduced the statistical power of the study and resulted in 
potential bias. Apart from those limitations above, to the 
best our knowledge, this was the first study evaluating 
the association between Vitamin D levels and VDR FokI 
polymorphism among diabetic foot patient in Indonesia.
Conclusion
Most individuals with diabetic foot tended to 
have mutant VDR FokI gene polymorphism and have 
low Vitamin D levels (Vitamin D insufficiency). These 
findings may highlight the potential role of Vitamin D 
in diabetic foot complications, even in the sunlight-rich 
areas of the tropical region like Indonesia. It would have 
been valuable if we had more information on Vitamin D 
status of our patients, and this should be considered in 
future studies.
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